COVID-19 Update – How the FDA’s Emergency Use Authorization Can Help Develop Therapies Faster

As we continue to face the ongoing COVID-19 health emergency, the medical community is tasked with bringing solutions to patients in an expedited and safe manner. One such opportunity is to partner with the US FDA by submitting an Emergency Use Authorization (EUA) for any products that could immediately and effectively address a health emergency.

In this episode, Nach Dave, Premier Research’s Vice President of Development Strategy, discusses key considerations for sponsors interested in applying for an EUA, including:

• How it allows the FDA to help strengthen the nation’s public health options
• How to know if your product is a good fit
• Actionable steps you can take toward seeking an EUA

Read our blog at https://premier-research.com/perspectives/what-is-fda-emergency-use-authorization-eua/.

Contact our COVID-19 Task Force at COVID-19_taskforce@premier-research.com.